Advertisement
Advertisement

MDXG

MDXG logo

MiMedx Group, Inc

5.20
USD
Sponsored
+0.08
+1.66%
Feb 02, 10:57 UTC -5
Open

MDXG Earnings Reports

Positive Surprise Ratio

MDXG beat 20 of 29 last estimates.

69%

Next Report

Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$109.07M
/
$0.07
Implied change from Q3 25 (Revenue/ EPS)
-4.09%
/
-53.33%
Implied change from Q4 24 (Revenue/ EPS)
+17.40%
/
+40.00%

MiMedx Group, Inc earnings per share and revenue

On Oct 29, 2025, MDXG reported earnings of 0.15 USD per share (EPS) for Q3 25, beating the estimate of 0.07 USD, resulting in a 110.08% surprise. Revenue reached 113.72 million, compared to an expected 96.03 million, with a 18.43% difference. The market reacted with a +2.92% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of 0.07 USD, with revenue projected to reach 109.07 million USD, implying an decrease of -53.33% EPS, and decrease of -4.09% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
FAQ
For Q3 2025, MiMedx Group, Inc reported EPS of $0.15, beating estimates by 110.08%, and revenue of $113.72M, 18.43% above expectations.
The stock price moved up 2.92%, changed from $7.19 before the earnings release to $7.40 the day after.
The next earning report is scheduled for Feb 24, 2026.
Based on 7 analysts, MiMedx Group, Inc is expected to report EPS of $0.07 and revenue of $109.07M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement